Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK

Long term pharmacological gastric acid suppression is a marker of increased risk of oesophageal and gastric adenocarcinoma. However, these associations are most likely explained by the underlying treatment indication being a risk factor for the cancer rather than an independent harmful effect of these agents per se.